PFSCF
|
Can you please point me to the information source where it says that Lmnl...
|
PFSCF
|
My understanding is that Lmnl still holds the IP on Ppps and related plasma...
|
PFSCF
|
Steve, I agree that once the Ryplazim BLA is filed, there is a very good...
|
PFSCF
|
Gobbs, you may be right that the company is finding it difficult to find a...
|
PFSCF
|
Gobbs, we already knew what the cash position was at the end of March. So...
|
PFSCF
|
Stockman, I was sad to see Moran and Gagnon and a large number of their...
|
PFSCF
|
Stockman, I was sad to see Moran and Gagnon and a large number of their...
|
PFSCF
|
Yes, Stockman I did take up the Rights Offering but suffered a major hit. I...
|
PFSCF
|
Yes, Tom I did ask myself that question many times. The answer I settled with...
|
PFSCF
|
The only problem Ulacin is that the current LoC only takes Lmnl till the end...
|
PFSCF
|
If current cash burn is maintained, Lmnl will have to raise funds thru an...
|
PFSCF
|
Ualcin, I am just repeating words that I read in the MDA. Covid...
|
PFSCF
|
The likely need for successive financings is also very sobering!
|
PFSCF
|
On Sedar. It is very sobering.
|
PFSCF
|
Justice, in addition to a corporate update on Ryplazim BLA and Alstrom trials...
|
PFSCF
|
Normally within 6 weeks after close of quarter so sometime next week.
|
PFSCF
|
Yes, it was sad to see Lynne Gagnon go. She specialised in pre-clinical work...
|
PFSCF
|
Biotech, I agree that the intention is to sell the company but it will...
|
PFSCF
|
Oh, the irony! Emergent is the CMO for Ryplazim at its Winnipeg facility. And...
|
PFSCF
|
Interesting that Lmnl has applied for govt funding to do a Covid plasma study...
|